Completed PHASE4 INTERVENTIONAL 2-arm NCT01356511

High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

High-dose Dexamethasone and Conventional Dose Prednisone, for the First-line Treatment of Adults With ITP: a Multicenter, Randomized Controlled, Clinical Trial

Sponsor: Anhui Provincial Hospital

Conditions Purpura, Thrombocytopenic, Idiopathic

Interventions Dexamethasone Prednisone

Updated 3 times since 2024 Last updated: Apr 18, 2016 Started: Sep 30, 2010 Primary completion: May 31, 2014 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Purpura, Thrombocytopenic, Idiopathic, this trial is completed. The trial is conducted by Anhui Provincial Hospital and has accumulated 3 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Aug 2025 — Sep 2025 [monthly]

Completed PHASE4
Sep 2024 — Aug 2025 [monthly]

Completed PHASE4

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anhui Provincial Hospital
Chinese Academy of Medical Sciences
Peking Union Medical College Hospital
People's Hospital of Xinjiang Uygur Autonomous Region
Ruijin Hospital
Second Hospital of Shanxi Medical University
Shandong University
Shandong University of Traditional Chinese Medicine
Shenzhen Second People's Hospital
Tongji Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Zhejiang Provincial Hospital of TCM

Data source: Shandong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jinan, China